MDxHealth Statistics
Total Valuation
MDxHealth has a market cap or net worth of $181.16 million. The enterprise value is $232.36 million.
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MDxHealth has 49.50 million shares outstanding. The number of shares has increased by 61.73% in one year.
| Current Share Class | 49.50M |
| Shares Outstanding | 49.50M |
| Shares Change (YoY) | +61.73% |
| Shares Change (QoQ) | +7.33% |
| Owned by Insiders (%) | 9.21% |
| Owned by Institutions (%) | 23.49% |
| Float | 35.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.65 |
| Forward PS | 1.44 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.31
| Current Ratio | 1.31 |
| Quick Ratio | 1.18 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.76 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -7.92% |
| Return on Invested Capital (ROIC) | -16.42% |
| Return on Capital Employed (ROCE) | -17.30% |
| Revenue Per Employee | $317,157 |
| Profits Per Employee | -$110,933 |
| Employee Count | 312 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 9.74 |
Taxes
In the past 12 months, MDxHealth has paid $103,000 in taxes.
| Income Tax | 103,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +39.70% in the last 52 weeks. The beta is -501,256.42, so MDxHealth's price volatility has been lower than the market average.
| Beta (5Y) | -501,256.42 |
| 52-Week Price Change | +39.70% |
| 50-Day Moving Average | 2.86 |
| 200-Day Moving Average | 2.14 |
| Relative Strength Index (RSI) | 65.69 |
| Average Volume (20 Days) | 175,204 |
Short Selling Information
| Short Interest | 62,085 |
| Short Previous Month | 62,966 |
| Short % of Shares Out | 0.15% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.39 |
Income Statement
In the last 12 months, MDxHealth had revenue of $98.95 million and -$34.61 million in losses. Loss per share was -$0.78.
| Revenue | 98.95M |
| Gross Profit | 62.86M |
| Operating Income | -17.20M |
| Pretax Income | -39.90M |
| Net Income | -34.61M |
| EBITDA | -11.19M |
| EBIT | -17.20M |
| Loss Per Share | -$0.78 |
Full Income StatementBalance Sheet
The company has $32.81 million in cash and $84.01 million in debt, giving a net cash position of -$51.20 million or -$1.03 per share.
| Cash & Cash Equivalents | 32.81M |
| Total Debt | 84.01M |
| Net Cash | -51.20M |
| Net Cash Per Share | -$1.03 |
| Equity (Book Value) | -883,000 |
| Book Value Per Share | -0.02 |
| Working Capital | 12.58M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$12.97 million and capital expenditures -$1.24 million, giving a free cash flow of -$14.21 million.
| Operating Cash Flow | -12.97M |
| Capital Expenditures | -1.24M |
| Free Cash Flow | -14.21M |
| FCF Per Share | -$0.29 |
Full Cash Flow StatementMargins
Gross margin is 63.53%, with operating and profit margins of -17.39% and -34.98%.
| Gross Margin | 63.53% |
| Operating Margin | -17.39% |
| Pretax Margin | -34.87% |
| Profit Margin | -34.98% |
| EBITDA Margin | -11.31% |
| EBIT Margin | -17.39% |
| FCF Margin | n/a |
Dividends & Yields
MDxHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -61.73% |
| Shareholder Yield | -61.73% |
| Earnings Yield | -19.11% |
| FCF Yield | -7.84% |
Analyst Forecast
The average price target for MDxHealth is $6.00, which is 63.93% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.00 |
| Price Target Difference | 63.93% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 25.41% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 14, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 14, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
MDxHealth has an Altman Z-Score of -3.06 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.06 |
| Piotroski F-Score | 4 |
